Biogen (BIIB) had the highest return since March 31, 2022 and in September 2022 by a US stock in the S&P 500 (GSPC), returning 37.1%.
| ASSET | % RETURN |
|---|---|
Biogen (BIIB) | 37.08% |
Regeneron Pharmaceuticals (REGN) | 19.26% |
Hubbell (HUBB) | 8.8% |
Robinhood Markets (HOOD) | 7.45% |
Eli Lilly and (LLY) | 7.43% |
Palantir Technologies (PLTR) | 6.83% |
Netflix (NFLX) | 6.67% |
First Solar (FSLR) | 6.22% |
Bristol-Myers Squibb (BMY) | 5.49% |
Wynn Resorts (WYNN) | 5.33% |
Interactive Brokers (IBKR) | 4.89% |
Newmont Goldcorp (NEM) | 4.42% |
Erie Indemnity (ERIE) | 4% |
TKO (TKO) | 3.8% |
Allstate (ALL) | 3.16% |
Globe Life (GL) | 3.01% |
Rollins (ROL) | 3% |
Vertex Pharmaceuticals (VRTX) | 2.8% |
Darden Restaurants (DRI) | 2.75% |
Fortinet (FTNT) | 2.27% |
Constellation Energy (CEG) | 1.96% |
PG&E (PCG) | 1.46% |
Builders FirstSource (BLDR) | 1.43% |
Merck (MRK) | 1.37% |
AutoZone (AZO) | 1.24% |